Kaufman Gerri
Department of Health Sciences, University of York, York, England.
Nurs Stand. 2016 May 25;30(39):52-60. doi: 10.7748/ns.30.39.52.s45.
Polypharmacy refers to the prescribing of many medicines for one individual. Polypharmacy is increasingly common as a result of the rise in multimorbidity, use of evidence-based clinical guidelines and care pathways, and a focus on disease prevention. Polypharmacy can be justified and appropriate, but it may also be inappropriate and associated with suboptimal health outcomes and mortality. Polypharmacy is associated with adverse drug events such as drug-drug interactions and adverse drug reactions (ADRs). Taking multiple medicines can adversely affect adherence, resulting in lost opportunities for health gain and wasted medicines. Older people, and particularly those who are frail, are susceptible to the adverse effects of polypharmacy. Medication reviews should be undertaken regularly in older people with polypharmacy. Medicines management systems, research, and education are essential to improve safe practice in the management of polypharmacy.
多重用药是指为一个人开具多种药物。由于共病情况增多、循证临床指南和照护路径的使用以及对疾病预防的关注,多重用药越来越普遍。多重用药可能是合理且恰当的,但也可能是不恰当的,并且与次优健康结果和死亡率相关。多重用药与不良药物事件相关,如药物相互作用和药物不良反应(ADR)。服用多种药物会对依从性产生不利影响,导致失去增进健康的机会和药物浪费。老年人,尤其是体弱的老年人,易受多重用药不良反应的影响。对于患有多重用药的老年人,应定期进行用药评估。药物管理系统、研究和教育对于改善多重用药管理中的安全实践至关重要。